Thank you for reading IJU this issue. This issue contains four Review Articles, 10 Original Articles, three Short Communications, one Procedure, one Perspectives in Urology and one Case Report, rich in variety.
One of the Review Articles was written by Kitajima et al. (Kobe, Japan) on positron emission tomography for imaging of prostate cancer. Imaging has recently become more important in the clinical management of prostate cancer patients, including diagnosis, staging, choice of optimal treatment strategy, treatment follow up and restaging. Positron emission tomography, a functional and molecular imaging technique, has opened a new field in clinical oncological imaging. The authors overview the potential and current use of positron emission tomography imaging employing the four most commonly used positron emission tomography radiotracers for imaging evaluation of prostate cancer.
The other Review Article was written by Sakakibara et al. (Sakura, Japan) on the pathophysiological role of cerebral white matter for overactive bladder. The authors overview white matter disease and overactive bladder. Small-vessel disease of the brain affecting the deep white matter characteristically manifests with neurological syndromes. There is compelling evidence to suggest that white matter disease can cause overactive bladder and incontinence, and in some patients these might be the initial manifestations.
The presence of lymph node metastasis in prostate cancer is not only of prognostic relevance, but also of therapeutic relevance. The risk of progression can be calculated, and appropriate adjuvant therapy can be planned. In addition, a direct therapeutic role of pelvic lymph node dissection in prostate cancer patients is still under discussion. Winter et al. (Oldenburg, Germany) investigated sentinel lymph node dissection in 1229 prostate cancer patients. They concluded that the rate of lymph node involvement seems to be higher in the examined sentinel collective than expected according to the European Guideline nomogram, and the first sentinel-based lymph node involvement prediction model can assist in deciding on the indication for sentinel-lymphadenectomy.
Finally, we are very happy that the articles published in International Journal of Urology have contributed to your clinical experiences and hopefully will continue to do so in the future.